APA (7th ed.) Citation

M, S., ZV, F., C, F. C., CR, F., H, L., F, L., . . . M, Q. (2024). Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma. Surgery, 175(2), 471. https://doi.org/10.1016/j.surg.2023.09.041

Chicago Style (17th ed.) Citation

M, Servin-Rojas, et al. "Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma." Surgery 175, no. 2 (2024): 471. https://doi.org/10.1016/j.surg.2023.09.041.

MLA (9th ed.) Citation

M, Servin-Rojas, et al. "Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma." Surgery, vol. 175, no. 2, 2024, p. 471, https://doi.org/10.1016/j.surg.2023.09.041.